Cephalexin (Keflex)

Cephalexin, widely known by the brand name Keflex, is a first-generation cephalosporin antibiotic commonly prescribed for the treatment of bacterial infections in cats. This oral antibiotic has been a cornerstone of veterinary antimicrobial therapy for decades, offering reliable activity against many gram-positive bacteria and some gram-negative organisms commonly causing infections in feline patients. Cephalexin remains one of the most frequently prescribed oral antibiotics in small animal practice due to its established efficacy, favorable safety profile, and wide availability in multiple formulations.

The mechanism of action of cephalexin follows the beta-lactam antibiotic principle of disrupting bacterial cell wall synthesis. The medication binds to penicillin-binding proteins within bacterial cell walls and inhibits the transpeptidase enzymes responsible for cross-linking peptidoglycan components. This interference weakens the bacterial cell wall structure, ultimately leading to osmotic instability and cell death. As a bactericidal antibiotic, cephalexin actively kills susceptible bacteria rather than merely inhibiting their growth, supporting effective infection clearance.

Cephalexin is available in several oral formulations including capsules, tablets, and liquid suspension, providing flexibility for administration to cats of various sizes and temperaments. The medication is typically administered two to three times daily depending on the specific infection and veterinary recommendation. While some cats accept oral medications readily, others may require creative administration techniques such as hiding medication in food or using pill pockets. The liquid suspension formulation can be particularly useful for cats resistant to swallowing capsules or tablets.

The safety profile of cephalexin in cats is well-established through extensive clinical use spanning many years. When administered at appropriate doses under veterinary supervision, most cats tolerate this antibiotic without significant adverse effects. As with all antibiotics, proper dosing, appropriate indication selection, and completion of the full treatment course are essential for optimal outcomes and responsible antibiotic stewardship. Veterinary guidance ensures that cephalexin is used appropriately for infections likely to respond to this first-generation cephalosporin.

Cephalexin is primarily indicated for the treatment of bacterial skin infections in cats, representing one of its most common applications in feline medicine. Superficial pyoderma, deep pyoderma, and infected wounds often harbor bacteria susceptible to cephalexin's activity against gram-positive organisms. Staphylococcal skin infections, which are common in cats, typically respond well to cephalexin therapy. The medication's ability to achieve therapeutic concentrations in skin tissue supports its effectiveness for dermatological infections of various severities.

Soft tissue infections beyond the skin constitute another important indication for cephalexin in cats. Abscesses, particularly those resulting from bite wounds during cat fights, frequently respond to cephalexin therapy when the causative bacteria are susceptible. While severe or deep abscesses may require surgical drainage in addition to antibiotic treatment, cephalexin provides appropriate antimicrobial coverage for many superficial to moderately deep soft tissue infections. The oral formulation allows for convenient home treatment following initial veterinary assessment.

Urinary tract infections in cats may be treated with cephalexin when susceptible organisms are involved. Bacterial cystitis and other lower urinary tract infections caused by gram-positive bacteria or susceptible gram-negative organisms can respond to cephalexin therapy. The medication achieves adequate concentrations in urine to address susceptible pathogens. Culture and sensitivity testing helps guide antibiotic selection for urinary infections, ensuring that cephalexin is appropriate for the specific bacteria present.

Bone infections, or osteomyelitis, represent a more specialized application for cephalexin in feline patients. The medication penetrates bone tissue reasonably well and can be effective against susceptible organisms causing bone infections. Treatment of osteomyelitis typically requires extended antibiotic courses, and cephalexin may be selected based on culture results showing susceptible pathogens. These serious infections require close veterinary monitoring throughout treatment.

Veterinarians select cephalexin over other antibiotics based on the suspected or confirmed bacterial pathogens, the site of infection, patient factors, and practical considerations. First-generation cephalosporins like cephalexin offer excellent gram-positive coverage with acceptable gram-negative activity, making them appropriate for many common feline infections. The medication's oral formulation, established safety record, and cost-effectiveness contribute to its frequent selection for appropriate indications.

Cephalexin dosing in cats is determined by the veterinarian based on the type and severity of infection, the cat's body weight, kidney function, and overall health status. Typical dosing protocols call for administration two to three times daily, with the total daily dose divided among these administrations. Dosing is calculated based on the cat's weight, typically ranging from 15 to 25 milligrams per kilogram per dose, though the veterinarian establishes the specific dose appropriate for each individual patient and situation.

The duration of cephalexin therapy varies depending on the infection being treated. Uncomplicated skin infections may require 7 to 14 days of treatment, while more serious or deep-seated infections may necessitate 3 to 4 weeks or longer. Urinary tract infections typically require 10 to 14 days of therapy to ensure complete bacterial eradication. Bone infections often require the longest treatment courses, sometimes extending for several weeks. The veterinarian determines appropriate treatment duration based on the specific clinical circumstances.

Administration of cephalexin can be accomplished with or without food, though giving the medication with a small amount of food may reduce gastrointestinal upset in sensitive cats and improve compliance. Capsules and tablets can be given directly or hidden in food, pill pockets, or other palatable treats. The liquid suspension formulation should be shaken well before each dose to ensure uniform drug distribution. Consistent timing of doses helps maintain therapeutic antibiotic levels throughout the treatment period.

If a dose of cephalexin is missed, it should be given as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular schedule resumed. Doses should never be doubled to compensate for missed doses, as this increases the risk of adverse effects without therapeutic benefit. Pet owners who struggle with consistent dosing should discuss the challenges with their veterinarian, who may offer strategies for improvement or consider alternative treatment approaches.

Completion of the full prescribed course of cephalexin is essential for successful infection resolution and prevention of antibiotic resistance. Even when cats appear clinically improved before finishing all medication, bacterial populations may not be fully eradicated. Stopping antibiotics prematurely allows surviving bacteria to potentially develop resistance and cause relapse or persistent infection. Pet owners should administer all prescribed doses and contact their veterinarian if concerns arise about continuing treatment.

Follow-up veterinary evaluation may be recommended to assess treatment response, particularly for serious infections or cases not showing expected improvement. If clinical signs persist or worsen despite appropriate therapy, culture and sensitivity testing may be performed to guide alternative antibiotic selection. Pet owners should monitor their cat throughout treatment and report any concerns or new symptoms to the veterinary team.

Cephalexin is generally well-tolerated by cats when administered at appropriate doses under veterinary supervision. The medication has an extensive safety track record spanning decades of clinical use in veterinary medicine. Most cats complete their prescribed courses without experiencing significant adverse effects. However, individual cats may show varying degrees of sensitivity, and pet owners should be aware of potential reactions during treatment.

Gastrointestinal effects are the most commonly reported adverse reactions to cephalexin in cats. Decreased appetite, nausea, vomiting, and diarrhea can occur as the antibiotic disrupts normal intestinal bacterial populations. These effects are typically mild and self-limiting, often resolving as treatment continues or shortly after completion. Administering cephalexin with food may help reduce gastrointestinal upset in sensitive cats. Persistent or severe digestive symptoms warrant veterinary consultation.

Soft stools and changes in stool consistency are frequently observed during cephalexin therapy. Disruption of the normal intestinal microbiome allows shifts in bacterial populations that can affect digestive function. These changes are usually temporary and resolve following treatment completion as healthy bacterial populations re-establish. Probiotic supplements formulated for cats may help support intestinal health during antibiotic therapy. Severe or bloody diarrhea requires immediate veterinary attention.

Allergic reactions to cephalexin can occur in cats with hypersensitivity to cephalosporin or penicillin-class antibiotics. Signs of allergic reaction include facial swelling, hives, skin rashes, difficulty breathing, or anaphylaxis. Any indication of allergic reaction requires immediate discontinuation of the medication and veterinary attention. Cats with known allergies to beta-lactam antibiotics should not receive cephalexin, and allergy history should be discussed with the veterinarian before treatment begins.

Less common side effects of cephalexin include excessive salivation, particularly if the medication has a bitter taste that cats detect, and changes in behavior or activity level. Rare adverse effects may include effects on blood cells or organ function with prolonged therapy. Pet owners should monitor their cat throughout the treatment period and report any unusual symptoms to their veterinarian. Early recognition of adverse effects allows prompt intervention and adjustment of therapy as needed.

Known hypersensitivity to cephalexin or other cephalosporin antibiotics constitutes the primary contraindication for this medication. Cats that have experienced previous allergic reactions to any cephalosporin should not receive cephalexin, as repeat exposure could trigger severe and potentially life-threatening reactions. Complete disclosure of any adverse reactions to antibiotics helps the veterinarian select safe and effective treatment alternatives.

Cross-reactivity between cephalosporins and penicillin antibiotics requires careful consideration when prescribing cephalexin. While true immunological cross-reactivity rates are lower than historically believed, cats with documented severe allergic reactions to penicillin-class antibiotics may be at elevated risk for reactions to cephalosporins. Veterinarians evaluate the nature and severity of previous antibiotic reactions when determining whether cephalexin is appropriate. Alternative antibiotic classes may be selected for cats with concerning allergy histories.

Significant kidney impairment influences cephalexin prescribing decisions due to the medication's primary renal elimination. Cats with advanced chronic kidney disease, a common condition in older felines, may experience delayed drug clearance leading to accumulation and increased risk of adverse effects. While mild to moderate kidney disease may not preclude cephalexin use, severe renal dysfunction typically requires dose adjustments or selection of alternative antibiotics. Blood work assessing kidney function helps guide appropriate treatment selection.

Pregnancy and lactation require careful evaluation before cephalexin administration. Cephalosporins as a class are generally considered relatively safe during pregnancy compared to some other antibiotic classes, as they have not shown significant teratogenic effects in available studies. However, the medication does cross the placenta and is excreted in milk, creating potential exposure for developing fetuses or nursing kittens. The decision to use cephalexin in pregnant or nursing cats involves weighing infection severity against potential risks, with veterinary guidance essential for these situations.

Complete disclosure of all medications, supplements, and treatments your cat receives is essential before starting cephalexin therapy. Drug interactions can affect medication effectiveness or increase the risk of adverse effects, making comprehensive medication history crucial for safe prescribing. Pet owners should inform their veterinarian of all current medications including prescription drugs, over-the-counter products, flea and tick preventatives, and dietary supplements.

Concurrent use of certain other antibiotics with cephalexin may result in interactions affecting efficacy or safety. Bacteriostatic antibiotics that inhibit bacterial growth without killing organisms could theoretically interfere with the bactericidal action of cephalosporins, though the clinical significance of this interaction is debated. Aminoglycoside antibiotics may have additive nephrotoxic potential when combined with cephalosporins, particularly at high doses or in patients with compromised kidney function. The veterinarian considers potential antibiotic interactions when combination therapy is contemplated.

Probenecid, a medication that affects renal tubular secretion, can increase cephalexin blood levels by competing for elimination pathways. While this interaction is rarely clinically relevant in feline practice, it illustrates how concurrent medications can affect antibiotic pharmacokinetics. Similarly, other medications eliminated through similar renal pathways may theoretically interact with cephalexin, though significant clinical interactions are uncommon at standard doses.

Dietary supplements and over-the-counter products should be reported to the veterinarian, as these can sometimes affect drug absorption or action. Probiotic supplements are generally considered safe and may even be beneficial during antibiotic therapy to support intestinal health. However, some supplements could potentially affect antibiotic absorption if administered simultaneously. The veterinary team can advise on appropriate timing of supplements during cephalexin treatment. Pet owners should maintain open communication about all products their cat receives and report any unusual symptoms during treatment.

General precautions for cephalexin use in cats include ensuring accurate body weight measurement for proper dose calculation and following veterinary instructions precisely regarding administration schedule and treatment duration. The frequency of dosing, typically two to three times daily, requires commitment from pet owners to maintain consistent administration. Incomplete dosing or shortened treatment courses can lead to treatment failure and contribute to antibiotic resistance development.

Breed-specific considerations for cephalexin relate primarily to underlying health conditions more common in certain breeds rather than direct breed-related drug sensitivities. Persian and Himalayan cats with higher rates of polycystic kidney disease may require kidney function evaluation before initiating antibiotics eliminated primarily through the kidneys. Similarly, breeds predisposed to other organ conditions may benefit from baseline screening. No specific breed contraindications have been established for cephalexin.

Owner compliance with the multiple daily dosing schedule represents an important consideration for cephalexin therapy success. Some cats resist oral medication administration, and the two to three times daily requirement can be challenging for busy pet owners. Strategies for improving compliance include hiding medication in palatable foods, using pill pockets or pill guns, or switching to liquid formulation for easier administration. Pet owners struggling with medication administration should discuss alternatives with their veterinarian.

Monitoring during cephalexin therapy focuses on clinical response to treatment and detection of any adverse effects. Improvement in infection signs such as reduced swelling, decreased discharge, improved appetite, and increased activity indicates positive treatment response. Conversely, worsening symptoms, failure to improve within expected timeframes, or development of new clinical signs should prompt veterinary consultation. Follow-up examination may be recommended for serious infections.

Special patient populations requiring additional consideration include geriatric cats with age-related kidney function decline, young kittens with developing organ systems, and immunocompromised patients. Cats with concurrent illnesses may have altered drug metabolism or increased susceptibility to adverse effects. The veterinarian integrates all patient factors when determining whether cephalexin represents the optimal treatment choice and establishes appropriate dosing and monitoring protocols.

Cephalexin capsules and tablets should be stored at controlled room temperature between 68 and 77 degrees Fahrenheit (20 to 25 degrees Celsius), protected from excessive heat, light, and moisture. The medication should be kept in its original container with the cap tightly closed to maintain stability. Storage locations should be secure and out of reach of children and pets to prevent accidental ingestion. Medications stored in bathroom medicine cabinets may be exposed to humidity from showers, which can affect stability.

Oral suspension formulations of cephalexin require specific handling and storage following reconstitution. The powder is typically mixed with water by pharmacy staff before dispensing, and the resulting liquid requires refrigeration to maintain potency. Reconstituted suspension is generally stable for 14 days when refrigerated at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius). The suspension should be shaken thoroughly before each dose to ensure uniform drug distribution. Pet owners should note the expiration date provided by the pharmacy and discard any remaining medication after this time.

Medication containers should be inspected before use to verify appropriate appearance and integrity. Capsules or tablets that appear damaged, discolored, or have unusual odors should not be administered. Liquid medication that shows unusual appearance, separation, or off-colors may indicate degradation. Expired medication should be discarded according to local pharmaceutical waste guidelines rather than administered, as potency cannot be guaranteed beyond expiration dates.

Disposal of unused cephalexin should follow local regulations for pharmaceutical waste. Unused capsules, tablets, or expired liquid medication should not be disposed of in regular household trash where they could be accessed by children or pets, nor should they be flushed into water systems where antibiotic contamination could contribute to environmental resistance. Many pharmacies and veterinary clinics offer medication take-back programs for safe disposal. Pet owners should consult their pharmacist or veterinarian regarding appropriate disposal methods in their area.

Cephalexin is generally well-tolerated across all cat breeds, with no established breed-specific contraindications for this antibiotic. The medication has been used successfully in cats of virtually every breed over its long history of veterinary use, with individual patient factors typically more important than breed in determining treatment outcomes. However, awareness of breed-related health predispositions helps veterinarians optimize patient selection and monitoring protocols.

Breeds with higher prevalences of kidney disease warrant consideration when selecting antibiotics eliminated primarily through the kidneys. Persian and Himalayan cats, with their genetic predisposition to polycystic kidney disease, may benefit from kidney function screening before extended antibiotic courses or when treating older individuals. Abyssinian cats and certain other breeds may have elevated rates of renal amyloidosis. While cephalexin is not contraindicated in cats with mild kidney impairment, dose adjustments or enhanced monitoring may be appropriate for cats with significant renal dysfunction.

Size variations among cat breeds influence dosing calculations but do not fundamentally affect cephalexin therapy. Larger breeds such as Maine Coons and Ragdolls require proportionally higher total doses based on body weight, while smaller cats receive correspondingly smaller amounts. Accurate weight measurement before treatment ensures appropriate dosing regardless of breed. Tablet or capsule strengths may need to be selected based on the calculated dose to allow accurate administration.

Age-related considerations apply across all breeds and significantly influence cephalexin therapy planning. Kittens have developing organ systems that may handle medications differently than adult cats, requiring attention to appropriate dosing. Geriatric cats, increasingly common given improved veterinary care, often have some degree of kidney function decline that may affect drug elimination. Breeds with shorter average lifespans may show age-related changes earlier than longer-lived breeds. The veterinarian considers the complete patient profile including breed, age, weight, and health status when establishing the treatment protocol.

Other first-generation cephalosporins provide alternatives with similar spectrum of activity to cephalexin. Cefadroxil is another oral first-generation agent that may be administered once or twice daily rather than the two to three times daily typically required for cephalexin, potentially improving owner compliance. Cefazolin is an injectable first-generation cephalosporin used in hospital settings for surgical prophylaxis or when parenteral therapy is preferred. These agents share similar antimicrobial coverage with cephalexin.

Extended-spectrum cephalosporins offer broader coverage when first-generation agents are insufficient. Cefpodoxime is an oral third-generation cephalosporin with enhanced gram-negative activity that may be selected for infections caused by resistant organisms. Cefovecin (Convenia) provides long-acting injectable therapy for cats that cannot tolerate oral medications, eliminating the need for daily dosing. These alternatives are selected based on culture results, clinical circumstances, and patient factors.

Non-cephalosporin antibiotics may be appropriate alternatives depending on the specific infection and bacterial susceptibilities. Amoxicillin-clavulanate provides broad-spectrum oral coverage including activity against beta-lactamase-producing bacteria and is available in palatable formulations. Fluoroquinolones offer different mechanisms of action for infections unresponsive to beta-lactam antibiotics. Clindamycin provides excellent coverage for anaerobic bacteria and deep tissue infections. The veterinarian selects antibiotics based on the specific clinical situation, culture results when available, and patient considerations.

Complementary supportive therapies may enhance treatment outcomes when used alongside cephalexin. Probiotic supplements formulated for cats can help maintain healthy intestinal flora during antibiotic treatment, potentially reducing gastrointestinal side effects. Nutritional support and appropriate wound care contribute to successful infection resolution. Pet owners should never substitute antibiotics without veterinary guidance, as inappropriate antibiotic selection can lead to treatment failure, prolonged infection, or development of antibiotic resistance.